SH2D2A and neoplasm: All wild type BALB/c mice, 55 % (6 out of 11) wild type Id-specific TCR-transgenic mice and 47 % (7 out of 15) SH2D2A-deficient Id-specific TCR-transgenic were sacrificed due to large tumor burden (>1 cm3) (Figure 6A).